Sanofi (SNY) Tops Q4 EPS by 79c

Sanofi (NASDAQ: SNY) reported Q4 EPS of EUR1.71, EUR0.79 better than the analyst estimate of EUR0.92. Revenue for the quarter came in at EUR10.72 billion versus the consensus estimate of EUR12.2 billion.

For earnings history and earnings-related data on Sanofi (SNY) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Guggenheim Defending Dianthus Therapeutics (DNTH): 'We reiterate our positive view'
• UBS Reiterates Neutral Rating on Lennar (LEN) Following Q2 Results